Movement Alert|Liquidia Technologies Rises 6.32% Overnight, Trading at $83.11

Market Focus06-29

On June 29, Liquidia Technologies rose 6.32% overnight, trading at $83.11 USD/share, with Turnover of $115,300.

Within the Pharmacy sector where Liquidia Technologies belongs, the overall sector performance was mixed. Among individual stocks, Eli Lilly up 1.98%, Johnson & Johnson down 0.18%, Merck down 0.23%, Axsome Therapeutics up 0%, Pfizer up 0%.

Liquidia Corporation is a biopharmaceutical company focused on the development, manufacturing, and commercialization of products to address unmet patient needs, with a current focus on pulmonary arterial hypertension treatment. Its lead product YUTREPIA has been commercially launched, with the most recent quarter delivering net product sales of approximately $130 million and more than 4,500 unique patient prescriptions received.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment